Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Repeated phencyclidine (PCP) administration induces cognitive disruptions resembling those seen in schizophrenia. Alterations in glutamate transmission and γ-aminobutyric acid (GABA) function in the prefrontal cortex (PFC) have been implicated in these PCP-induced deficits, as well as in cognitive symptoms of schizophrenia. PCP-induced cognitive deficits are reversed by chronic treatment with the atypical antipsychotic clozapine in rats. We investigated the effects of a single injection vs. repeated administration of PCP on glutamate levels in the PFC using in vivo microdialysis. Furthermore, we examined how these PCP regimens affect GABA neuronal markers in the PFC. Finally, we investigated the effects of clozapine on disruptions in glutamate levels and GABA neuronal markers induced by repeated PCP administration. Acute PCP administration (2 mg/kg) increased extracellular PFC glutamate; this increase appeared blunted, but was not eliminated, after repeated PCP pretreatment. PCP administration also strongly decreased levels of parvalbumin and glutamic acid decarboxylase-67 (two markers of GABA function) in the PFC, an effect that was maintained after a 10 day drug-free washout period and unaltered by the resumption of repeated PCP injections. All of the observed PCP effects were attenuated by chronic treatment with clozapine, an atypical antipsychotic that has partial effectiveness on cognitive impairment in schizophrenia. These findings suggest that abnormal cortical glutamate transmission, possibly driven by pathological changes in GABA function in parvalbumin-positive fast-spiking interneurons, may underlie some of the cognitive deficits in schizophrenia. A better understanding of glutamate and GABA dysregulation in schizophrenia may uncover new treatment targets for schizophrenia-related cognitive dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
Sohal, V. S., Zhang, F., Yizhar, O., & Deisseroth, K. (2009) · Nature · doi:10.1038/nature07991 · Cited by 2,606 · cited 4×
“Parvalbumin-positive GABA neurons form a subpopulation of fast-spiking inhibitory interneurons (Kawaguchi and Kondo, 2002) that play a key role in the generation of synchronized gamma oscillations, which in turn are thought to be crucially important for information processing in the brain (Bartos et al., 2007; Cardin…”
BackgroundInfluentialDriving fast-spiking cells induces gamma rhythm and controls sensory responses
Cardin, J. A., Carlén, M., Meletis, K., Knoblich, U., Zhang, F., Deisseroth, K., Tsai, L.-H., & Moore, C. I. (2009) · Nature · doi:10.1038/nature08002 · Cited by 2,603
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070 · cited 4×
“…binding protein located within a subpopulation of fast-spiking GABAergic interneurons centrally involved in information processing in the brain (Bartos et al., 2007; Cardin et al., 2009; Sohal et al., 2009), and glutamic acid decarboxylase-67 (GAD67), the main isoform of the synthesizing…”
BackgroundInfluentialMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · cited 3×
“Introduction Glutamate abnormalities reported in schizophrenia patients (Tamminga, 1998) are proposed to be involved in schizophrenia pathology (Olney and Farber, 1995), including cognitive © 2011 Elsevier Ltd.”
BackgroundHomayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · cited 2×
“Electrophysiological studies confirm this prediction for several brain areas (Grunze et al., 1996; Li et al., 2002), including the PFC (Homayoun and Moghaddam, 2007; Zhang et al., 2008).”
BackgroundGABAergic Interneurons Implications for Understanding Schizophrenia and Bipolar Disorder
Benes, F. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00225-1 · Cited by 1,082 · cited 2×
“Importantly, evidence of disturbed GABA function in schizophrenia patients has been found in numerous studies (for review, see Benes and Berretta, 2001; Lewis et al., 2004).”
BackgroundAkbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938 · cited 5×
“PFC tissue from schizophrenia patients also showed reductions in parvalbumin mRNA (Hashimoto et al., 2003) and protein (Beasley et al.”
BackgroundInfluentialCognitive Impairment in Schizophrenia Is the Core of the Disorder
Elvevag, B., & Goldberg, T. E. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.10 · Cited by 835 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript deficits that are core features of the disorder (Elvevag and Goldberg, 2000).”
BackgroundVolk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · cited 4×
“Sustained treatment with another NMDA receptor antagonist, ketamine, decreased levels of parvalbumin and GAD67 in cultured GABA interneurons in vitro (Behrens et al., 2007;Kinney et al., 2006), and in the PFC of mice (Behrens et al.”
BackgroundMethodSelf-citationDissociating executive functions of the prefrontal cortex.
Robbins, T. W. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0131 · Cited by 574 · cited 1×
“…NMDA receptor antagonist administration increases extracellular glutamate levels in the prefrontal cortex (PFC; Moghaddam et al., 1997), a brain region critically involved in cognition (Fuster, 1973; Robbins, 1996) and implicated in cognitive deficits in schizophrenia (Weinberger et al., 1986).”
BackgroundKrystal, J. H., D'Souza, D. C., Mathalon, D., Perry, E., Belger, A., & Hoffman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1582-z · Cited by 530 · cited 1×
“…state evoked by NMDA receptor antagonists in humans is present only during intoxication and dissipates after clearance of the drug from the body (Adler et al., 1998; Cho et al., 2005; Krystal et al., 1994, 2003; Malhotra et al., 1996; Meltzer et al., 1972; Pradhan, 1984; Rosenbaum et al., 1959).”
BackgroundNMDA-dependent modulation of CA1 local circuit inhibition
Grunze, H., Rainnie, D., Hasselmo, M., Barkai, E., Hearn, E., McCarley, R., & Greene, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02034.1996 · Cited by 467 · cited 2×
“Electrophysiological studies confirm this prediction for several brain areas (Grunze et al., 1996; Li et al., 2002), including the PFC (Homayoun and Moghaddam, 2007; Zhang et al., 2008).”
BackgroundParvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
BEASLEY, C., & REYNOLDS, G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00122-3 · Cited by 426
Kawaguchi, Y., & Kondo, S. (2002) · Journal of Neurocytology · doi:10.1023/a:1024126110356 · Cited by 395 · cited 2×
“Parvalbumin-positive GABA neurons form a subpopulation of fast-spiking inhibitory interneurons (Kawaguchi and Kondo, 2002) that play a key role in the generation of synchronized gamma oscillations, which in turn are thought to be crucially important for information processing in the brain (Bartos et al.”
BackgroundBeasley, C. L., Zhang, Z. J., Patten, I., & Reynolds, G. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01360-4 · Cited by 374 · cited 2×
“PFC tissue from schizophrenia patients also showed reductions in parvalbumin mRNA (Hashimoto et al., 2003) and protein (Beasley et al., 2002; Beasley and Reynolds, 1997), as well as the number of cells expressing GABA transporter-1 (GAT-1) mRNA (Volk et al., 2001).”
BackgroundKinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329 · cited 3×
“…preferential blockade by NMDA receptor antagonists appears to particularly affect parvalbumin-containing GABA interneurons, possibly because of a higher ratio of NR2A to NR2B subunits in the NMDA receptors expressed on these neurons compared with glutamatergic pyramidal cells (Kinney et al., 2006).”
BackgroundSelf-citationLewis, D., Volk, D., & Hashimoto, T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1673-x · Cited by 253 · cited 2×
“Importantly, evidence of disturbed GABA function in schizophrenia patients has been found in numerous studies (for review, see Benes and Berretta, 2001; Lewis et al., 2004).”
BackgroundLópez-Gil, X., Babot, Z., Amargós-Bosch, M., Suñol, C., Artigas, F., & Adell, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301356 · Cited by 183 · cited 3×
“…in our laboratory after systemic saline injections, and the existing literature reports no effects of such saline injections on extracellular glutamate levels in the PFC and other brain areas (e.g., Abekawa and Koyama, 2006; Abekawa et al., 2007; Adams and Moghaddam, 1998; Lopez-Gil et al., 2007).”
BackgroundResult
Cited by
Reviewing the ketamine model for schizophrenia
Frohlich, J., & Van Horn, J. D. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113512909 · Cited by 303
Driesen, N. R., McCarthy, G., Bhagwagar, Z., Bloch, M., Calhoun, V, D'Souza, D. C., Gueorguieva, R., He, G., Ramachandran, R., Suckow, R. F., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.194 · Cited by 224
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Phillips, K. G., Cotel, M. C., McCarthy, A. P., Edgar, D. M., Tricklebank, M., O’Neill, M. J., Jones, M. W., & Wafford, K. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.006 · Cited by 100
Gomes, F. V., Issy, A. C., Ferreira, F. R., Viveros, M.-P., Del Bel, E. A., & Guimarães, F. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu041 · Cited by 89
Metadata
- Authors
- Amitai, N., Kuczenski, R., Behrens, M. M., & Markou, A.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 62
- Issue
- 3
- Pages
- 1422-1431
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2092036317
- Cited by
- 92
- References
- 23
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.